Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KLA Corp. (KLAC) vs Liquidia Corporation Common Stock (LQDA) Price & Performance

Liquidia Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

KLA Corp. vs Liquidia Corporation Common Stock — how do they compare? KLA Corp. trades at $174.48 (market cap $233.35B), while Liquidia Corporation Common Stock trades at $33.75 (market cap $3.04B). The key difference: KLA Corp. is far larger — about 76.8× Liquidia Corporation Common Stock's market cap, and KLA Corp. pays a 0.51% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold KLA Corp. for 60 Days and Liquidia Corporation Common Stock for 0 Days on average.

KLACLQDA
Market Cap
$233.35B$3.04B
Volume
14,457,69921,111,778
Sector
TechnologyHealth
52-Week High
$301.71$91.03
52-Week Low
$108.70$22.02
Typical Hold Time
60 Days0 Days
Enterprise Value
$234.60B$2.94B
Dividend Yield
0.51%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KLA Corp.

KLA Corporation (KLAC) trades at $184.00, down 3.22% on the day, with strong fundamental performance including 35.57% net income margin and 87.5% ROE. The stock shows bullish technical signals with recent earnings beats and a $12.57 billion backlog driven by AI demand. Revenue grew to $12.16 billion in 2025, with analysts projecting $13.6 billion for 2026.

Outlook remains positive with 63.6% analyst buy ratings and $223.88 consensus price target, representing 22% upside. Key risks include competitive pressures from AMAT and ASML, margin compression, and cyclical semiconductor equipment spending. The company's dominant position in semiconductor inspection equipment supports long-term growth prospects.

Liquidia Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KLAC
100% Buy0% Sell
Avg holding period · 60 Days
LQDA
62% Buy38% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About KLA Corp.

KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.

Read more on KLAC →

About Liquidia Corporation Common Stock

Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.

Read more on LQDA →